Sustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption

Journal of Virology

Volumn 87, Issue 20, 2013, Pages 11088-11095

  Rezaee, Fariba ^a   DeSando, Samantha A ^a   Ivanov, Andrei I ^b   Chapman, Timothy J ^a   Knowlden, Sara A ^a   Beck, Lisa A ^a   Georas, Steve N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTACTIN; PROTEIN KINASE D;

ACTIN FILAMENT; ARTICLE; BRONCHUS MUCOSA; CELL DISRUPTION; CELL GROWTH; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS REPLICATION;

CELL CULTURE TECHNIQUES; CELL LINE; CYTOSKELETAL PROTEINS; ELECTRIC CONDUCTIVITY; EPITHELIAL CELLS; HUMANS; PROTEIN KINASE C; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84886883949     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01573-13     Document Type: Article

References (49)

1. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. 2009. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360:588-598.
2. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simoes EA, Rudan I, Weber MW, Campbell H. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545-1555.
3. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352:1749-1759.
4. Lotz MT, Peebles RS, Jr. 2012. Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr. Allergy Asthma Rep. 12: 380-387.
5. Domachowske JB, Bonville CA, Mortelliti AJ, Colella CB, Kim U, Rosenberg HF. 2000. Respiratory syncytial virus infection induces expression of the anti-apoptosis gene IEX-1L in human respiratory epithelial cells. J. Infect. Dis. 181:824-830.
6. Sajjan U, Wang Q, Zhao Y, Gruenert DC, Hershenson MB. 2008. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am. J. Respir. Crit. Care Med. 178:1271-1281.
7. Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, Haitchi HM, Vernon-Wilson E, Sammut D, Bedke N, Cremin C, Sones J, Djukanovic R, Howarth PH, Collins JE, Holgate ST, Monk P, Davies DE. 2011. Defective epithelial barrier function in asthma. J. Allergy Clin. Immunol. 128:549-556.
8. Niessen CM. 2007. Tight junctions/adherens junctions: basic structure and function. J. Investig. Dermatol. 127:2525-2532.
9. Rezaee F, Meednu N, Emo JA, Saatian B, Chapman TJ, Naydenov NG, De Benedetto A, Beck LA, Ivanov AI, Georas SN. 2011. Polyinosinic: polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells. J. Allergy Clin. Immunol. 128:1216-1224.
10. Valverde AM, Sinnett-Smith J, Van Lint J, Rozengurt E. 1994. Molec-ular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. U. S. A. 91:8572-8576.
11. Eiseler T, Schmid MA, Topbas F, Pfizenmaier K, Hausser A. 2007. PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett. 581:4279-4287.
12. Eiseler T, Hausser A, De Kimpe L, Van Lint J, Pfizenmaier K. 2010. Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J. Biol. Chem. 285:18672-18683.
13. Bougneres L, Girardin SE, Weed SA, Karginov AV, Olivo-Marin JC, Parsons JT, Sansonetti PJ, Van Nhieu GT. 2004. Cortactin and Crk cooperate to trigger actin polymerization during Shigella invasion of epithelial cells. J. Cell Biol. 166:225-235.
14. Monick M, Staber J, Thomas K, Hunninghake G. 2001. Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J. Immunol. 166:2681-2687.
15. San-Juan-Vergara H, Peeples ME, Lockey RF, Mohapatra SS. 2004. Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells. J. Virol. 78:13717-13726.
16. Hallak LK, Spillmann D, Collins PL, Peeples ME. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74:10508-10513.
17. Rezaee F, Gibson LF, Piktel D, Othumpangat S, Piedimonte G. 2011. Respiratory syncytial virus infection in human bone marrow stromal cells. Am. J. Respir. Cell Mol. Biol. 45:277-286.
18. Groskreutz DJ, Monick MM, Yarovinsky TO, Powers LS, Quelle DE, Varga SM, Look DC, Hunninghake GW. 2007. Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J. Immunol. 179:2741-2747.
19. Bitko V, Shulyayeva O, Mazumder B, Musiyenko A, Ramaswamy M, Look DC, Barik S. 2007. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J. Virol. 81: 1786-1795.
20. Ivanov AI. 2008. Actin motors that drive formation and disassembly of epithelial apical junctions. Front. Biosci. 13:6662-6681.
21. George A, Pushkaran S, Li L, An X, Zheng Y, Mohandas N, Joiner CH, Kalfa TA. 2010. Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species. Blood Cells Mol. Dis. 45:41-45.
22. Sharlow ER, Giridhar KV, LaValle CR, Chen J, Leimgruber S, Barrett R, Bravo-Altamirano K, Wipf P, Lazo JS, Wang QJ. 2008. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. J. Biol. Chem. 283:33516-33526.
23. Turner JR. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9:799-809.
24. Comstock AT, Ganesan S, Chattoraj A, Faris AN, Margolis BL, Hershenson MB, Sajjan US. 2011. Rhinovirus-induced barrier dysfunction in polarized airway epithelial cells is mediated by NADPH oxidase 1. J. Virol. 85:6795-6808.
25. Singh D, McCann KL, Imani F. 2007. MAPK and heat shock protein 27 activation are associated with respiratory syncytial virus induction of human bronchial epithelial monolayer disruption. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L436-L445.
26. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ. 2002. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110:789-799.
27. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. 2002. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76:5654-5666.
28. Nishikawa K, Toker A, Johannes FJ, Songyang Z, Cantley LC. 1997. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:952-960.
29. Sinnett-Smith J, Rozengurt N, Kui R, Huang C, Rozengurt E. 2011. Protein kinase D1 mediates stimulation of DNA synthesis and proliferation in intestinal epithelial IEC-18 cells and in mouse intestinal crypts. J. Biol. Chem. 286:511-520.
30. Sinnett-Smith J, Jacamo R, Kui R, Wang YM, Young SH, Rey O, Waldron RT, Rozengurt E. 2009. Protein kinase D mediates mitogenic signaling by Gq-coupled receptors through protein kinase C-independent regulation of activation loop Ser744 and Ser748 phosphorylation. J. Biol. Chem. 284:13434-13445.
31. Ziegler S, Eiseler T, Scholz RP, Beck A, Link G, Hausser A. 2011. A novel protein kinase D phosphorylation site in the tumor suppressor Rab interactor 1 is critical for coordination of cell migration. Mol. Biol. Cell 22: 570-580.
32. Matthews SA, Navarro MN, Sinclair LV, Emslie E, Feijoo-Carnero C, Cantrell DA. 2010. Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. Biochem. J. 432:153-163.
33. Kim YI, Park JE, Brand DD, Fitzpatrick EA, Yi AK. 2010. Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula. J. Immunol. 184:3145-3156.
34. Ren M, Feng H, Fu Y, Land M, Rubin CS. 2009. Protein kinase D is an essential regulator of C. elegans innate immunity. Immunity 30:521-532.
35. Bravo-Altamirano K, George KM, Frantz MC, Lavalle CR, Tandon M, Leimgruber S, Sharlow ER, Lazo JS, Wang QJ, Wipf P. 2011. Synthesis and structure-activity relationships of benzothienothiazepinone inhibitors of protein kinase D. ACS Med. Chem. Lett. 2:154-159.
36. George KM, Frantz MC, Bravo-Altamirano K, Lavalle CR, Tandon M, Leimgruber S, Sharlow ER, Lazo JS, Wang QJ, Wipf P. 2011. Design, synthesis, and biological evaluation of PKD inhibitors. Pharmaceutics 3:186-228.
37. Sharlow ER, Mustata Wilson G, Close D, Leimgruber S, Tandon M, Reed RB, Shun TY, Wang QJ, Wipf P, Lazo JS. 2011. Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity. PLoS One 6:e25134. doi:10.1371/journal.pone.0025134.
38. Cohen P. 2010. Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem. J. 425:53-54.
39. Iglesias T, Waldron RT, Rozengurt E. 1998. Identification of in vivo phosphorylation sites required for protein kinase D activation. J. Biol. Chem. 273:27662-27667.
40. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. 2000. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161:1501-1507.
41. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. 1999. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541-545.
42. Peebles RS, Jr. 2004. Viral infections, atopy, and asthma: is there a causal relationship? J. Allergy Clin. Immunol. 113:S15-S18.
43. Becker S, Reed W, Henderson FW, Noah TL. 1997. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am. J. Physiol. 272:L512-L520.
44. Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75:9044-9058.
45. Piedimonte G, Hegele RG, Auais A. 2004. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatr. Res. 55:657-665.
46. King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G. 2001. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am. J. Respir. Cell Mol. Biol. 24:101-107.
47. Piedimonte G. 2003. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 22:S66-S75.
48. Bauer G, Bossi L, Santoalla M, Rodriguez S, Farina D, Speranza AM. 2009. Impact of a respiratory disease prevention program in high-risk preterm infants: a prospective, multicentric study. Arch. Argentin. Pediatr. 107:111-118. (In Spanish).
49. IMpact-RSV Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531-537.